Berkshire reduces Apple stake, FDA to review Moderna vaccine
Morning Brief host Julie Hyman takes a look at some of Wednesday morning's trending tickers and stories. Moderna (MRNA) stock is surging on the US Food and Drug Administration's (FDA's) decision to review the company's flu vaccine, reversing its earlier rejection. New York Times (NYT) stock is on the rise after Berkshire Hathaway (BRK-B, BRK-A) announced a $350 million stake in the news outlet. Berkshire also reduce…
AI brief
Pulse reads the full article- What happened
- Why it matters
- What to watch
Sign in to get the AI brief. Pulse explains what happened, why it matters, what to watch and who's exposed. Free for members.
Sign in to read the brief
